Endocannabinoid (EC) receptor, CB1, and EC enzymes' expression in primary adipocyte cultures of Lean and Obese Pre-pubertal Children in Relation to Adiponectin and Insulin

Journal of Pediatric Endocrinology and Metabolism

Volumn 23, Issue 10, 2010, Pages 1011-1024

  Karvela, Alexia ^a   Paola Rojas Gi, Andrea ^a   Samkinidou, Efstratia ^c   Papadaki, Helen ^b   Pappa, Aliki ^a   Georgiou, George ^c   Spiliotis, Bessie E ^a  

^a Research Laboratory of the Division of Pediatric Endocrinology   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c Karamandaneio Hospital of Patras   (Greece)

Author keywords

Adiponectin; CB1; Children; Endocannabinoids; Insulin; Insulin resistance; Obesity

Indexed keywords

ACYLGLYCEROL LIPASE; ADIPONECTIN; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; FATTY ACID HYDROLASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; N ACYLPHOSPHATIDYL ETHANOLAMINE HYDROLYSING PHOSPHOLIPASE D; SN 1 SELECTIVE DIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; BODY MASS; CELL CULTURE; CHILD; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFRARED SPECTROMETRY; LEAN BODY WEIGHT; MALE; OBESITY; PREPUBERTY; PRESCHOOL CHILD; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; TISSUE CULTURE; WESTERN BLOTTING;

ADIPOCYTES; ADIPONECTIN; BLOOD PRESSURE; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; ENDOCANNABINOIDS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INSULIN; INSULIN RESISTANCE; LIPOPROTEIN LIPASE; MALE; OBESITY; RECEPTOR, CANNABINOID, CB1; RNA, MESSENGER; THINNESS;

EID: 79951470005     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem.2010.162     Document Type: Article

References (42)

1. Wilson RI, Nicoll RA. Endocannabinoid signaling in the brain. Science (New York, NY 2002; 296: 678-682.
2. Taube A, Eckardt K, Eckel J. Role of lipid-derived mediators in skeletal muscle insulin resistance. Am J Physiol Endocr Metab 2009; 297: E1004-E1012.
3. Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 2004; 24: 53-62. (Pubitemid 38181669)
4. Kirkham TC, Williams CM. Endogenous cannabinoids and appetite. Nutr Res Rev 2001; 14: 65-86. (Pubitemid 32574404)
5. Walker JM, Hohmann AG, Martin WJ, Strangman NM, Huang SM, Tsou K. The neurobiology of cannabinoid analgesia. Life Sci 1999; 65: 665-673. (Pubitemid 29362772)
6. Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O. Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology 2002; 159: 379-387. (Pubitemid 34143362)
7. Cota D, Woods SC. The role of the endocannabinoid system in the regulation of energy homeostasis. Curr Opin Endocrin Diabetes 2005; 12: 338-351. (Pubitemid 41433815)
8. Bellocchio L, Cervino C, Pasquali R, Pagotto U. The endocannabinoid system and energy metabolism. Journal of neuroendocrinology 2008; 20: 850-857. (Pubitemid 351863320)
9. Matias I, Di Marzo V. Endocannabinoids and the control of energy balance. Trends in endocrinology and metabolism: TEM 2007; 18: 27-37. (Pubitemid 44960014)
10. Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, Schubert M, et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. The Journal of clinical investigation 2003; 112: 423-431. (Pubitemid 38063771)
11. Devane WA, Dysarz FA, 3rd, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Molecular pharmacology 1988; 34: 605-613 (Pubitemid 19007296)
12. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocrine reviews 2006; 27: 73-100. (Pubitemid 43228239)
13. Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G, Oury-Donat F, et al. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Molecular pharmacology 2003; 63: 908-914. (Pubitemid 36368998)
14. Motaghedi R, McGraw TE. The CB1 endocannabinoid system modulates adipocyte insulin sensitivity. Obesity (Silver Spring, Md 2008; 16: 1727-1734.
15. Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Martin BR. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. Curr Med Chem 1999; 6: 721-744. (Pubitemid 29399501)
16. Pagano C, Rossato M, Vettor R. Endocannabinoids, adipose tissue and lipid metabolism. Journal of neuroendocrinology 2008; 20 Suppl 1: 124-129. (Pubitemid 351559285)
17. Sipe JC, Waalen J, Gerber A, Beutler E. Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH). Int J Obes (Lond) 2005; 29: 755-759. (Pubitemid 40897010)
18. Chiang K, Gerber AL, Sipe JC, Cravatt BF. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum Molec Genet 2004; 13: 1-7.
19. Sipe JC, Scott TM, Murray S, Harismendy O, Simon GB, Cravatt BF, Waalen J. Biomarkers of endocannabinoid system activation in severe obesity. PLos one 2010; 5(1): 1-6.
20. Poirier B, Bidouard JP, Cadrouvele C, Marniquet X, Staels B, O'Connor SE, et al. The anti-obesity effect of rimonabant is associated with an improved serum lipid profile. Diabetes, obesity & metabolism 2005; 7: 65-72.
21. Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, Maffrand JP, et al. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in dietinduced obese mice. American journal of physiology 2003; 284: R345-353. (Pubitemid 36120150)
22. Di Marzo V, Despres J-P. CB1 antagonists for obesity-what lessons have we learned from rimonabant? Nat Rev Endocrinol 2009 Nov 5(11): 633-638.
23. Hannon TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatric research 2006; 60: 759-763. (Pubitemid 44789522)
24. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovasular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 1999; 103: 1175-1182. (Pubitemid 29258789)
25. Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children. Diabetologia 1996; 39: 1489-1497. (Pubitemid 26397355)
26. Bacha F, Gungor N, Lee S, Arslanian SA. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance and type 2 diabetes? Diabetes Care. 2009; January, 32(1): 100-105.
27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif 2001; 25: 402-408. (Pubitemid 34164012)
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
29. McCarthy HD, Jarrett KV, Crawley HF. The development of waist circumference percentiles in British children aged 5. 0-16. 9 y. European journal of clinical nutrition 2001; 55: 902-907. (Pubitemid 32927057)
30. Hirschler V, Aranda C, Calcagno Mde L, Maccalini G, Jadzinsky M. Can waist circumference identify children with the metabolic syndrome? Archives of pediatrics & adolescent medicine 2005; 159: 740-744. (Pubitemid 41126836)
31. Hirschler V, Maccallini G, Calcagno M, Aranda C, Jadzinsky M. Waist circumference identifies primary school children with metabolic syndrome abnormalities. Diabetes technology & therapeutics 2007; 9: 149-157. (Pubitemid 46652549)
32. Savva SC, Tornaritis M, Savva ME, Kourides Y, Panagi A, Silikiotou N, et al. Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes Relat Metab Disord 2000; 24: 1453-1458.
33. Matias I, Gonthier MP, Orlando P, Martiadis V, De Petrocellis L, Cervino C, et al. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. The Journal of clinical endocrinology and metabolism 2006; 91: 3171-3180. (Pubitemid 44271774)
34. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. The Journal of biological chemistry 2004; 279: 12152-12162. (Pubitemid 38445780)
35. Hannon TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatric research 2006;60: 759-763. (Pubitemid 44789522)
36. Arslanian SA, Kalhan SC. Protein turnover during puberty in normal children. The American journal of physiology 1996; 270: E79-84.
37. Roemmich JN, Rogol AD. Hormonal changes during puberty and their relationship to fat distribution. Am J Hum Biol 1999; 11: 209-224. (Pubitemid 129726291)
38. Di Marzo V, Matias I. Endocannabinoid control of food intake and energy balance. Nature neuroscience 2005; 8: 585-589. (Pubitemid 40594198)
39. Pagano C, Pilon C, Calcagno A, Urbanet R, Rossato M, Milan G, et al. The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calciumdependent mechanisms. The Journal of clinical endocrinology and metabolism 2007; 92: 4810-4819. (Pubitemid 350223464)
40. Bluher M, Engeli S, Kloting N, Berndt J, Fasshauer M, Batkai S, et al. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 2006; 55: 3053-3060. (Pubitemid 44923642)
41. Cote M, Matias I, Lemieux I, Petrosino S, Almeras N, Despres JP, et al. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. International journal of obesity (2005) 2007; 31: 692-699. (Pubitemid 46482358)
42. Morrison JA, Glueck CJ, Horn PS, Schreiber GB, Wang P. Pre-teen insulin resistance predicts weight gain, impaired fasting glucose and type 2 diabetes at age 18-19y: a 10y prospective study of black and white girls. Am J Clin Nutr. 2008 Sep;88(3): 778-88.